Our favorite Carlsbad-based life sciences company Invitrogen just spent $6.4 billion to purchase “scientific instruments-maker Applera’s Applied Biosystems Group.”
Invitrogen will pay $38 per share for Applied Biosystems, representing a 17 percent premium to the stock’s closing price Wednesday. . . . The deal, which needs the approval of both companies’ shareholders, is expected to close this fall.
About 45 percent of the deal will reportedly be in cash, the rest of stock. Invitrogen’s shares dropped nearly $6 a share on the news and is now trading at $38.97. Up .24 on the day.
And we thought Invitrogen couldn’t get any scarier.
[Link: Chicago Tribune]
RSS Feed-Posts
{ 0 comments… add one now }